SCHEMBL29638511

SCHEMBL29638511

COc1ccc(Nc2nccc3cc(C)ccc23)c(F)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 4/20 0.47
HDAC3 O15379 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
CLK1 P49759 3/20 0.44
TRPA1 O75762 1/20 0.44
GSK3B P49841 2/20 0.43
CCNT1 O60563 1/20 0.43
CDK9 P50750 1/20 0.43
RAF1 P04049 1/20 0.43
BRAF P15056 1/20 0.43
DYRK3 O43781 1/20 0.41
CLK2 P49760 1/20 0.41
CLK3 P49761 1/20 0.41
GSK3A P49840 1/20 0.41
DYRK2 Q92630 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
DYRK4 Q9NR20 1/20 0.41
DYRK1B Q9Y463 1/20 0.41
KDR P35968 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638579 0.90 TRPA1 (0.44) DYRK1AHDAC3HDAC1HDAC6TRPA1
SCHEMBL29638531 0.88 HDAC3 (0.53) HDAC3HDAC1HDAC6RAF1BRAF
SCHEMBL29638608 0.88 HDAC3 (0.46) DYRK1AHDAC3HDAC1HDAC6RAF1
SCHEMBL29638530 0.82 HDAC3 (0.44) HDAC3HDAC1HDAC6RAF1BRAF
SCHEMBL29638533 0.81 NCOA1 (0.60) KDRNCOA1NCOA3MAPTEGFR
SCHEMBL26208965 0.79 DYRK1A (0.43) DYRK1ACLK1GSK3BCCNT1CDK9
Hydrochloric Acid SCHEMBL9378828 0.75 ALDH1A1 (0.44) CDK9EGFR
SCHEMBL23624380 0.74 TNF (0.50) TRPA1KDRFLT1FGFR1EGFR
SCHEMBL25375020 0.74 MAPT (0.42) DYRK1ACLK1GSK3BCCNT1CDK9
SCHEMBL29638713 0.74 RAPGEF4 (0.41) HDAC3HDAC1HDAC6TRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022089219-A1 ARYLAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND PREPARATION METHOD THEREFOR AND USE THEREOF 四川科伦博泰生物医药股份有限公司 2022-05-05 WO disclosed